GGrantIndex
← Leaderboards

Johnathan D Tune

Louisiana State Univ Hsc New Orleans

$5,694,763
Attributed
$9,432,611
Total exposure
5
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $902.3K · FY200525
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$9,432,611 · 5

By mechanism

R01$8,943,864 · 4
T35$488,747 · 1

Top collaborators

Most similar at Louisiana State Univ Hsc New Orleans

Same institution · by research overlap

Others in their field

Top investigators on “Obesity

Research focus

ObesityCardiovascular SystemInsightRegulationFamily SuidaeMetabolicBlood FlowCoronaryConsciousIn VivoImpairmentInstrumentReceptorHypertensionMolecularHeartOxygenAnimalsMetabolic SyndromeMyocardialIn VitroCardiacInsulin ResistanceMyocardial Perfusion

Grant awards (22)

Disentangling the Mechanisms of Coronary Blood Flow Regulation through Multi-scale Modeling$642,502
R01 · FY2025 · HL
Disentangling the Mechanisms of Coronary Blood Flow Regulation through Multi-scale Modeling$641,539
R01 · FY2024 · HL
Developing a Structurally-Motivated Model of Coronary Microcirculation Mechanics and Hemodynamics$79,445
R01 · FY2024 · HL
Disentangling the Mechanisms of Coronary Blood Flow Regulation through Multi-scale Modeling$654,748
R01 · FY2023 · HL
Disentangling the Mechanisms of Coronary Blood Flow Regulation through Multi-scale Modeling$668,090
R01 · FY2022 · HL
Short-Term Training Program In Biomedical Sciences$246,447
T35 · FY2018 · HL
Cardiovascular effects of GLP-1 in obesity/metabolic syndrome$660,047
R01 · FY2017 · HL · contact PI
Short-Term Training Program In Biomedical Sciences$242,300
T35 · FY2017 · HL
Cardiovascular effects of GLP-1 in obesity/metabolic syndrome$663,167
R01 · FY2016 · HL · contact PI
Cardiovascular effects of GLP-1 in obesity/metabolic syndrome$662,933
R01 · FY2015 · HL · contact PI
Cardiovascular effects of GLP-1 in obesity/metabolic syndrome$709,525
R01 · FY2014 · HL · contact PI
Cardiovascular effects of GLP-1 in obesity/metabolic syndrome$678,907
R01 · FY2013 · HL · contact PI
Cardiovascular effects of GLP-1 in obesity/metabolic syndrome$30,604
R01 · FY2013 · HL · contact PI
Mechanisms of coronary microvascular dysfunction in metabolic syndrome$377,817
R01 · FY2012 · HL · contact PI
Mechanisms of coronary microvascular dysfunction in metabolic syndrome$381,731
R01 · FY2011 · HL · contact PI
Mechanisms of coronary microvascular dysfunction in metabolic syndrome$381,826
R01 · FY2010 · HL · contact PI
Mechanisms of coronary microvascular dysfunction in metabolic syndrome$381,919
R01 · FY2009 · HL · contact PI
Coronary dysfunction in obesity and insulin resistance$369,849
R01 · FY2006 · HL · contact PI
Coronary dysfunction in obesity and insulin resistance$188,934
R01 · FY2005 · HL
Coronary dysfunction in obesity and insulin resistance$126,405
R01 · FY2005 · HL
Coronary dysfunction in obesity and insulin resistance$316,247
R01 · FY2004 · HL
Coronary dysfunction in obesity and insulin resistance$327,629
R01 · FY2003 · HL